Citation Impact
Citing Papers
Testosterone-induced downregulation of anti-Müllerian hormone expression in granulosa cells from small bovine follicles
2009
Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
2018 Standout
The effects of oxidative stress on female reproduction: a review
2012 Standout
Anti-Müllerian hormone (AMH): Regulator and marker of ovarian function
2010
Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
2014
Hepatocellular carcinoma
2016 Standout
Follicle dynamics and anovulation in polycystic ovary syndrome
2008
Serum anti-Mullerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation
2010
Comparison of serum anti-Müllerian hormone levels in normal weight and overweight–obese adolescent patients with polycystic ovary syndrome
2014
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
2014
Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
2011
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome
2008
Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-müllerian hormone and inhibin-B
2007
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Anti-Müllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels
2008
Is polycystic ovary syndrome an exception for reproductive aging?
2010
Serum Anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum Follicle Stimulating Hormone (FSH) levels
2011
Fertility and infertility: Definition and epidemiology
2018 Standout
Is foetal hyperexposure to androgens a cause of PCOS?
2017
Equine Metabolic Syndrome
2010 Standout
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
2011
Executive summary of the Stages of Reproductive Aging Workshop + 10
2012 Standout
Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features
2012
Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells
2011
Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
2016
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Type 2 diabetes mellitus
2015 Standout
Anti-Mullerian hormone (AMH): what do we still need to know?
2009
Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?
2012
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
2009
Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones
2005
Loss of LH-induced down-regulation of anti-Mullerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome
2013
Polycystic ovary syndrome
2016 Standout
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries
2012
Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients
2010
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Interpreting human follicular recruitment and antimüllerian hormone concentrations throughout life
2012
Anti-Müllerian hormone and ovarian dysfunction
2008
PCOS Forum: research in polycystic ovary syndrome today and tomorrow
2010
Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.
1976 Standout
Anti-MüLlerian Hormone as a Marker of Ovarian Reserve: An Update
2008
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Role of Oxidative Stress in Polycystic Ovary Syndrome
2010
Variations in the Pattern of Pubertal Changes in Boys
1970 Standout
Serum Anti-Mullerian Hormone Concentrations Are Elevated in Oligomenorrheic Girls without Evidence of Hyperandrogenism
2010
Hormonal Profile in Women with Polycystic Ovarian Syndrome with or without Type 1 Diabetes Mellitus
2007
Interrelationships between Ovarian and Pituitary Hormones in Ovulatory Menstrual Cycles across Reproductive Age
2008
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
2015
Unleash Metformin
2013
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Changes in Serum Anti-Mullerian Hormone Level during Low-Dose Recombinant Follicular-Stimulating Hormone Therapy for Anovulation in Polycystic Ovary Syndrome
2007
Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes
2014
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
2016
Anti-Mullerian Hormone, Its Receptor, FSH Receptor, and Androgen Receptor Genes Are Overexpressed by Granulosa Cells from Stimulated Follicles in Women with Polycystic Ovary Syndrome
2008
Works of H Brain being referenced
Granulosa Cell Production of Anti-Müllerian Hormone Is Increased in Polycystic Ovaries
2006
Metformin‐associated lactic acidosis: a rare or very rare clinical entity?
1999